Common use of Ongoing Studies Clause in Contracts

Ongoing Studies. Salix will cooperate with Progenics to transfer any on-going clinical studies for which it has responsibility hereunder in which patient dosing has commenced or, if reasonably practicable and requested by Progenics, allow Progenics to complete such trials (and then assign all related Regulatory Documentation and investigator and other agreements relating to such studies), all at Salix’s expense.

Appears in 2 contracts

Sources: License Agreement (Salix Pharmaceuticals LTD), License Agreement (Progenics Pharmaceuticals Inc)